scholarly journals Neonatal SARS-CoV-2 Infection: Practical Tips

Pathogens ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 611
Author(s):  
Cinzia Auriti ◽  
Domenico De Rose ◽  
Vito Mondì ◽  
Ilaria Stolfi ◽  
Chryssoula Tzialla ◽  
...  
Keyword(s):  
Distress Syndrome ◽  
Clinical Care ◽  
Age Groups ◽  
Severe Pneumonia ◽  
Late Pregnancy ◽  
Clinical Syndrome ◽  
Upper Respiratory Tract ◽  
Young Infants ◽  
Upper Respiratory ◽  
A New Species

The recent viral pandemic in Wuhan, Hubei, China has led to the identification of a new species of beta-coronavirus, able to infect humans, the 2019-nCoV, later named SARS-CoV-2. SARS-CoV-2 causes a clinical syndrome named COVID-19, which presents with a spectrum of symptoms ranging from mild upper respiratory tract infection to severe pneumonia, with acute respiratory distress syndrome and frequent death. All age groups are susceptible to the infection, but children, especially infants, seem to be partially spared, having a more favorable clinical course than other age groups. There is currently no clear evidence showing vertical transmission and intrauterine SARS-CoV-2 infection in fetuses of women developing COVID-19 pneumonia in late pregnancy, and even if transmission is possible, the SARS-CoV2 positivity of the mother does not require delivery by caesarean section, does not contraindicate the management of the infant in rooming-in and allows breastfeeding. This review provides an overview on the biology of the virus, on the pathogenesis of the infection, with particular attention to pregnancy and neonatal age, on the clinical presentation of infection in newborns and young infants and summarizes the international recommendations currently available on the clinical care of neonates with SARS-CoV2 infection or at risk of catching the virus. The main objective of the review is to provide an update especially focused to the clinical management of COVID-19 infection in the perinatal and neonatal age.

scholarly journals COVID-19 infected neonate presenting with cytokine storm and sepsis

2021 ◽  
Vol 8 (7) ◽  
pp. 1296
Author(s):  
Mallesh Kariyappa ◽  
Sahana Devadas ◽  
Aparna Dutt ◽  
Varun Govindarajan
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Case Report ◽  
Tract Infection ◽  
Inflammatory Markers ◽  
Distress Syndrome ◽  
Clinical Syndrome ◽  
Cytokine Storm ◽  
Upper Respiratory Tract ◽  
Intravenous Antibiotics ◽  
Upper Respiratory

COVID-19, a clinical syndrome caused by the coronavirus (SARS-CoV-2) became a pandemic following an outbreak of viral pneumonitis, first identified in Wuhan, China. The disease manifestations vary ranging from mild upper respiratory tract infection to severe pneumonitis, acute respiratory distress syndrome (ARDS) and even death. Although most of the neonatal cases are asymptomatic, rarely, they can present with cytokine storm mimicking with similar features of sepsis. This is a case report of SARS-CoV19 positive neonate presenting with sepsis and cytokine storm, 5-day old baby born to SARS-COVID 19 positive mother presented with fever and investigations showed elevated total counts with neutrophilic predominance, thrombocytopenia suggestive of sepsis and increased inflammatory markers suggestive of cytokine storm. Blood culture was sent and baby was started on intravenous antibiotics. In view of cytokine storm intravenous dexamethasone 0.5 mg/kg/day was given intravenously for 5 days. Neonate recovered from illness after 1 week as evidenced clinically and and by the fall in inflammatory markers before discharge. This report opens the possibility of having both sepsis and cytokine storm in a SARS-CoV19 positive neonate.

Otorhinolaryngological manifestations of COVID-19

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Jarosław Wysocki
Keyword(s):  
Respiratory Tract ◽  
Distress Syndrome ◽  
Clinical Symptoms ◽  
Wide Spectrum ◽  
Multiple Organ ◽  
Upper Respiratory Tract ◽  
Equilibrium System ◽  
Similar Frequency ◽  
Upper Respiratory ◽  
Loss Of Strength

COVID-19 manifests itself in a wide spectrum of clinical symptoms, both in terms of their variety and severity. It can be asymptomatic or abortive, mild, moderate, severe and lightning, as septic with multiple organ failure and shock Typical leading symptoms of COVID-19 are: high fever poorly responding to drugs, severe loss of strength, chest pain, dyspnoea, pain headaches, bone and joint pain and muscle pain, until the onset of acute respiratory distress syndrome (ARDS). However, many publications mention among the possible symptoms also others, not related to the involvement of the lower respiratory tract. These are gastrointestinal disorders, damage to the central and peripheral nervous system, catarrh of the upper respiratory tract and dysfunctions of the sensory organs. The aim of this literature review was to determine the frequency of various head and neck dysfunctions that are part of COVID-19. Symptoms of conjunctivitis, nasal mucosa, pharynx and larynx are reported by about of patients, but they do not always occur at the same time, as in infections caused, for example, by rhinoviruses. Anosmi / hyposmia or ageusia / hypogeusia occur with a similar frequency. Symptoms of damage to the equilibrium system, such as dizziness, are reported by approx. 1/3, vertigo and hearing loss approx. 5-6%, tinnitus approx. 10% of patients. Reports of coexistence with COVID-19 of peripheral paresis of the facial nerve are so far relatively few and often included in the neurological disorders, the frequency of which is also about 1/3 of COVID-19 cases. Importantly, both catarrhal symptoms and the others listed here may precede, co-occur or follow the appearance of the leading symptoms of COVID-19. They can also be the only symptoms of this disease. This should prompt otorhinolaryngologists to be particularly vigilant in this regard

scholarly journals Challenges in the delivery of critical care in India during the COVID-19 pandemic

2020 ◽  
pp. 175114372095259
Author(s):  
Bharath Kumar Tirupakuzhi Vijayaraghavan ◽  
Sheila Nainan Myatra ◽  
Meghena Mathew ◽  
Nirmalyo Lodh ◽  
Jigeeshu Vasishtha Divatia ◽  
...  
Keyword(s):  
Critical Care ◽  
Acute Respiratory Distress Syndrome ◽  
Intensive Care ◽  
Respiratory Tract ◽  
Respiratory Distress Syndrome ◽  
Distress Syndrome ◽  
Upper Respiratory Tract ◽  
Care Services ◽  
Life Threatening ◽  
Upper Respiratory

Coronavirus disease 2019 cases in India continue to increase and are expected to peak over the next few weeks. Based on some projection models, India is expected to have more than 10 million cases by September 2020. The spectrum of disease can vary from mild upper respiratory tract symptoms to life-threatening acute respiratory distress syndrome and multi-organ failure requiring intensive care. Even if less than 5% of patients require critical care services, this will still rapidly overwhelm the healthcare system in a country, where intensive care services and resources are scarce and unevenly distributed. In this perspective article, we highlight the critical care preparedness of India for the pandemic and the associated challenges.

scholarly journals Human Infection withFusobacterium necrophorumwithout Jugular Venous Thrombosis: A Varied Presentation of Lemierre’s Syndrome

2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Muhammad Asim Rana ◽  
Yashwant Kumar ◽  
Abdullah Ali Lashari ◽  
Ahmed F. Mady
Keyword(s):  
Nerve Palsy ◽  
Jugular Vein ◽  
Kidney Injury ◽  
Severe Pneumonia ◽  
Fusobacterium Necrophorum ◽  
Human Infection ◽  
Upper Respiratory Tract ◽  
Lemierre’S Syndrome ◽  
Upper Respiratory ◽  
Lemierre's Syndrome

Lemierre’s syndrome is also known as postangina septicemia, which is commonly caused byFusobacterium necrophorumalso known as Necrobacillus and also by other microorganisms likeStaphylococcus,Streptococcus,Peptostreptococcus, andBacteroides. Though the disease starts as an upper respiratory tract infection, it may spread and cause thrombophlebitis of the internal jugular vein. It may present itself through cranial nerve palsy or sepsis involving distant organs like the lungs or bones. It is also known as forgotten disease because of its rarity.Fusobacterium necrophorumusually causes infection in animals and rarely affects humans. We hereby present a case of Necrobacillus infection which did not cause any thrombophlebitis but resulted in severe pneumonia and acute kidney injury, leading to respiratory failure and requiring mechanical ventilation.

scholarly journals Spectrum of Influenza B Viral Infection in Indian Children: A Tertiary Centre Experience

2018 ◽  
Vol 38 (3) ◽  
pp. 170-175 ◽  
Author(s):  
Sandesh Kini ◽  
Ramesh Bhat Y ◽  
Koushik Handattu ◽  
Phalguna Kousika ◽  
Chennakeshava Thunga
Keyword(s):  
Tract Infection ◽  
Respiratory Tract ◽  
Viral Infection ◽  
Respiratory Tract Infection ◽  
Severe Pneumonia ◽  
Upper Respiratory Tract Infection ◽  
Influenza B Virus ◽  
Influenza B ◽  
Upper Respiratory Tract ◽  
Upper Respiratory

Introduction: Influenza viral infection in children can range from subclinical illness to multi system involvement. The morbidity associated with influenza B viral infection is often overlooked. India being the second most populous country, accounts for 20% of global childhood deaths from respiratory infections. There is paucity of data on the clinical features and complications of influenza B viral infections in children from the Indian subcontinent. Our objective was to study the clinical profile, seasonality, complications and outcome associated with Influenza B viral infection in children < 18 years of age. Material and Methods: We conducted a retrospective observational study at a tertiary care hospital in South India. Children less than 18 years of age admitted to our paediatric unit were included in the study. We reviewed the case sheets of 56 patients who tested positive for influenza B virus during the study period and recorded their clinical and laboratory data. Throat swab obtained from cases were tested by RT-PCR. The illness was classified as upper respiratory tract infection, pneumonia and severe pneumonia. Outcome measures analysed were- mortality, need for oxygen supplementation or assisted ventilation, duration of oxygen support, duration of ICU/ hospital stay and time for defervescence following initiation of oseltamivir therapy. Results: The mean age of the study population was 6.98 years. Majority of the affected children were > 5 years of age in the school going category with a male to female ratio of 3:2. The diagnosis based on clinical and radiological findings included upper respiratory tract infection (URTI) in 44 (78.5%) cases followed by pneumonia in 11(19.6%) and severe pneumonia in one (1.7%) child. The peak incidence was in the month of March. Malnutrition was the most common risk factor affecting 22 (39.3%) cases followed by history of asthma in eight (14.3%). Three children required oxygen supplementation at admission. The median duration of hospital stay was seven days. The median duration for defervescence following initiation of oseltamivir therapy was 24 hours. Mortality was recorded in one infant who died of acute respiratory distress syndrome. Conclusions: Influenza B virus should be screened in all children having underlying high risk medical condition, presenting with pneumonia or upper respiratory tract infection. Oseltamivir therapy should be initiated early in the management of influenza B viral infections to prevent complications.

scholarly journals A RANDOMISED CONTROL STUDY TO COMPARE THE EFFICACY OF CEFUROXIME, CLARITHROMYCIN, AND LEVOFLOXACIN IN THE MANAGEMENT OF PAEDIATRIC UPPER RESPIRATORY TRACT INFECTION

2021 ◽  
pp. 103-106
Author(s):  
GOUTHAMI PADUGUNDLA ◽  
JYOTHIRMAYEE V ◽  
BETHALA RAVALI ◽  
JAGILLAPURAM ARUNDHATHI ◽  
THAKUR SRILATHA ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Age Distribution ◽  
Age Groups ◽  
Efficacy Rate ◽  
Pool Data ◽  
Upper Respiratory Tract ◽  
Cure Rate ◽  
Significant Difference ◽  
Upper Respiratory ◽  
Tract Infections

Background: The upper respiratory infections cause considerable morbidity mainly in children due to the fact that they mainly affect children. Accordingly, a study was conducted on antibiotics to compare the effectiveness of clarithromycin, cefuroxime, and levofloxacin for treating upper respiratory tract infections (URTI) in children. Methods: A prospective observational study for a period of 6 months was conducted in the pediatrics department of RVM hospital. Outpatients under the age of 14 years given antibiotics for the treatment of URTI were included in the study. A total of 99 study subjects were included in the study, divided into three groups each containing 33 sample sizes (clarithromycin, cefuroxime, and levofloxacin). Patient data was collected using a form and verbal consent was obtained from patients/patient representatives, and drugs were given using the lottery method. Follow-up was done and noted for the 3rd, 5th, 7th day through telephonic calls, and the collected data were evaluated using statistical analysis. Results: Pool data from 99 patients shows that many patients belong to 0–5 years age groups (age distribution), and males were more than female (gender distribution). Clarithromycin (cure rate 3 days) and cefuroxime (cure rate 5 days) showed an equal rate of cure percentage (94%), while levofloxacin for 3–5 days with a 3% failure rate. A significant difference of p<0.05 (p=0.000) was observed and no adverse events were noted. Conclusion: The study findings showed, out of 3 drugs, clarithromycin and cefuroxime showed an equal efficacy rate of 94%, but clarithromycin showed shorter duration of outcome, i.e., 3 days. Hence, clarithromycin is effective than the other two drugs in the treatment of URTI.

scholarly journals Acute Respiratory Distress Syndrome Caused by Human Adenovirus in Adults: A Prospective Observational Study in Guangdong, 2019–2020

2021 ◽  
Author(s):  
Zhan Wu ◽  
Rong Zhang ◽  
Dongdong Liu ◽  
Xuesong Liu ◽  
Jierong Zhang ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Clinical Characteristics ◽  
Distress Syndrome ◽  
Early Stage ◽  
Invasive Mechanical Ventilation ◽  
Viral Pneumonia ◽  
Upper Respiratory Tract ◽  
Shortness Of Breath ◽  
Upper Respiratory

Abstract Background: Viral causes of acute respiratory distress syndrome (ARDS) are mostly limited to influenza. However, adenovirus has been emerging as a cause of ARDS with a high mortality rate and described in adults are rare.Methods: We conducted a prospective, single-center observational study of viral pneumonia with ARDS and confirmed adenovirus-associated ARDS in adults at our quaternary referral institution between March 2019 and June 2020. We prospectively analyzed clinical characteristics, laboratory test results, radiological characteristics, viral load from nasopharyngeal swabs and endotracheal aspirates, treatments, and outcomes for the study participants.Results: The study enrolled 143 ARDS patients, including 47 patients with viral pneumonia-related ARDS, among which there were 14 adenovirus-associated ARDS patients, which accounted for 29.79% of the viral pneumonia-related ARDS cases. Among the adenovirus-associated ARDS patients, 78.57% were men with a mean age of 54.93 ± 19.04 years. Adenovirus-associated ARDS patients had no specific clinical characteristics, but they presented with shortness of breath and fever, and their initial chest radiographic findings were multifocal or showed diffuse opacity. The viral load and the positivity rate in the lower respiratory tract were higher than that of the upper respiratory tract in the patients with adenovirus-associated ARDS, and 85.71% of the patients had a significant decrease in the number of CD3+CD4+ T cells during the early stage. All patients required invasive mechanical ventilation treatment. The average time from shortness of breath to the application of invasive ventilation was 24 hours. The median duration of invasive mechanical ventilation was 22 days (14–75 days). Six patients (42.86%) required renal replacement therapy, and three patients (21.43%) required extracorporeal membrane oxygenation support. Additionally, 85.71% of the 14 adenovirus-associated ARDS patients survived.Conclusion: Adenovirus infection is an important cause of virus-related ARDS. The positivity rate of adenovirus infection in lower respiratory tract secretions was higher than that in upper respiratory tract secretions in these patients. Most of the patients had a significant decrease in the number of CD3+CD4+ T cells during the early stage. Early identification and intervention to prevent disease progression are essential for reducing the mortality rate in these patients.

scholarly journals ROLE OF BILWADI AGADA IN PREVENTION OF COVID - 19

2020 ◽  
Vol 8 (7) ◽  
pp. 3939-3944
Author(s):  
Varun Rajpuria ◽  
Anitta James
Keyword(s):  
Prevention And Control ◽  
Distress Syndrome ◽  
The Body ◽  
Ayurvedic Medicine ◽  
Pharmacological Properties ◽  
Upper Respiratory Tract ◽  
Corona Virus ◽  
Upper Respiratory ◽  
And Control

Agada Tantra is a specialized branch of Ayurveda which mainly deals with Visha (Poison) and its management mainly through special formulations called Agada Yogas which counteract the deleterious actions of poison over the body. There are numerous such formulations which are unique because of their potent ingredients and fast action. Bilwadi Agada is one among such Yogas. In December 2019, a series of acute atypical respiratory disease occurred in Wuhan and then rapidly spread to other areas. It was soon discovered that a novel Corona Virus was responsible, and this was named as the Severe Acute Respiratory Syndrome Corona Virus-2 (2019) due to its high homology to SARS-CoV-2 which caused Acute Respiratory Distress Syndrome and high mortality during 2002–2003 in China. According to Ayurveda, this novel Corona is a Jangama Visha as it is of zoonotic origin. It affects the upper respiratory tract so is the movement of Jangama Visha which moves upward and affects those areas. It is also mentioned in Ayurvedic treatise that the Jangaman Visha should be treated with Sthavara dravyas. Bilwadi gutika is an Ayurvedic medicine prepared from thirteen medicinal plants triturated in goat’s urine. When we compare the primary symptoms of COVID-19 and the indications of Bilwadi gutika, we can see so many similarities. The main objective of this article is to discuss the therapeutic and pharmacological properties of Bilwadi Agada and thereby understanding its role in prevention and control of COVID-19 pandemic.

Symptom Analysis of Confirmed Covid-19 Patients Managed at Allied Hospitals of Rawalpindi Medical University, Pakistan

1970 ◽  
Vol 9 (4) ◽  
pp. 235-241
Author(s):  
Javeria Malik ◽  
Muhammad Khurram ◽  
Arsalan Manzoor Mughal ◽  
Noman Ahmed Chaudhary ◽  
Qaiser Aziz ◽  
...  
Keyword(s):  
Age Groups ◽  
Severe Pneumonia ◽  
Cross Sectional Study ◽  
Upper Respiratory Tract ◽  
Shortness Of Breath ◽  
Cross Sectional ◽  
Duration Of Symptoms ◽  
Presenting Symptoms ◽  
Persistent Cough ◽  
Medical University

Introduction Coronavirus can cause respiratory disease ranging from mild upper respiratory tract illness to severe pneumonia, severe acute respiratory distress syndrome, and death. The purpose of this research was to study the symptoms of confirmed Coronavirus disease (COVID-19) cases and their relationship with gender and age groups. Materials and Methods This observational cross-sectional study was conducted at Rawalpindi Institute of Urology and Transplantation (RIUT) that is the COVID-19 management center of Rawalpindi Medical University, Rawalpindi during the month of March 2020. Consecutive sampling methodology was used, and all real-time polymerase chain reaction (RT-PCR) confirmed patients of COVID-19 were included. Data regarding age, gender, and symptoms with onset was recorded and analyzed.  Results Thirty-five patients, 22 (62.9%) males, and 13 (37.1%) females were included. Seven (20%) patients were ≥60 years old, and 12 (34.8%) ≥40 years old. 21 (60%) were symptomatic and the rest of them were asymptomatic. The mean duration of symptoms was 2.8±1.1 days. Fever (13, 61.9%), persistent cough (12, 57.1%), sputum (6, 28.6%), shortness of breath (4, 19%), anorexia (3, 14.3%), fatigue (3, 14.3%), myalgia (1, 4.8%), were presenting symptoms. Cough, anorexia, and fatigue were significantly more frequent in the patients ≥40 of age. Anorexia and fatigue were common in the age groups ≥40 and ≥60 years. Myalgia was significantly frequent in patients aged ≥60 years. Conclusion Fever, persistent cough and shortness of breath are commonest symptoms of COVID 19 patients. COVID-19 can be asymptomatic in many cases.

Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities on COVID-19

2021 ◽  
Vol 17 ◽  
Author(s):  
Suruchi Singh ◽  
Pankaj Bhatt ◽  
Satish Kumar Sharma ◽  
Tejinder Kaur
Keyword(s):  
Risk Factor ◽  
Severe Acute Respiratory Syndrome ◽  
Severe Pneumonia ◽  
Cardiovascular Disorder ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Inflammatory Cardiomyopathy ◽  
Cardiovascular Comorbidity ◽  
Upper Respiratory ◽  
Body Response

: Many studies have approved that COVID-19 disease was caused by Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus-1(SARS-CoV-1), and has spread as an epidemic from across the world today. Initially, it affects the upper respiratory tract, induces viral infection in the lungs, and causes severe pneumonia in the COVID-19 infected patients. After the infection in the body, changes appear in other biomarkers in the body therby imbalancing the body response studied by the virus's pathophysiology. However, this infection starts comorbidity directly and indirectly in COVID-19 infected patients. During this period of infection, the immune system is also suppressed by the virus and initiates other diseases. The authors focus on the cardiovascular comorbidity study of COVID-19 in the current work. In the comorbidity study of COVID-19, the virus mainly affects hypertension patients. The risk factor of comorbidity of hypertension and cardiovascular disorder is 30.7%, and 11.9% with diabetes mellitus. In this study, we reveal the pathophysiology, treatment, and management of cardiovascular diseases, their risk factor, and medicine results on the COVID-19 infected patients. SARS-CoV-2 primarily targets ACE-2 receptors because this virus receives this receptor as a host for the cellular entry of the virus in the body, these shows down regulations in the maintenance of BP, and the body suffers from multi-organ failure. The other diseases related to CVS are Inflammatory cardiomyopathy, congestive heart failure, irregular heartbeat, embolism events, and Coronary infarction that also affect its pathophysiology.

Sign in / Sign up

Export Citation Format

Share Document